Fluicell AB (publ)
Fluicell AB (publ) operates as a life science company, provides platforms and research solutions for bioprinting and single-cell biology. The company offers BIOPEN, a microfluidic platform for high-precision single-cell solution delivery that enables to control the cell microenvironment without moving or disturbing the cells; Biozone 6 that generate dose-response curves or study the effects of mu… Read more
Fluicell AB (publ) (5J90) - Total Liabilities
Latest total liabilities as of September 2025: €5.58 Million EUR
Based on the latest financial reports, Fluicell AB (publ) (5J90) has total liabilities worth €5.58 Million EUR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Fluicell AB (publ) - Total Liabilities Trend (2021–2024)
This chart illustrates how Fluicell AB (publ)'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Fluicell AB (publ) Competitors by Total Liabilities
The table below lists competitors of Fluicell AB (publ) ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lambo Group Bhd
KLSE:0018
|
Malaysia | RM17.52 Million |
|
Vanadiumcorp Resource Inc
PINK:VRBFF
|
USA | $2.24 Million |
|
Maytronics
TA:MTRN
|
Israel | ILA1.15 Billion |
|
DAVITA HLTH CARE - Dusseldorf Stock Exchang
DU:TRL
|
Germany | €15.28 Billion |
|
MDI Energia S.A.
WAR:MDI
|
Poland | zł87.24 Million |
|
C I Systems
TA:CISY
|
Israel | ILA21.00 Million |
|
Jayden Resources Inc.
OTCQB:JDNRF
|
USA | $900.14K |
|
Poseidon Nickel Limited
PINK:PSDNF
|
USA | $65.02 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down Fluicell AB (publ)'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.52 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.34 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Fluicell AB (publ)'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Fluicell AB (publ) (2021–2024)
The table below shows the annual total liabilities of Fluicell AB (publ) from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €6.27 Million | -29.62% |
| 2023-12-31 | €8.91 Million | +7.15% |
| 2022-12-31 | €8.32 Million | +5.72% |
| 2021-12-31 | €7.87 Million | -- |